Furthermore, integrating genetic and epigenetic analyses—such as the role of circadian regulation genes (e.g., CLOCK and BMAL1) or APOE variations—could elucidate individual variability in sleep-dementia pathways and support the development of personalized interventions. This evidence concerns the gene APOE and dementia.